Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CEPHALEXIN

CEPHALEXIN

Standard Dose
EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons*
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CEPHALEXIN is listed in Drugs@FDA under application 062117 (ANDA).

Marketing status: Discontinued Active ingredient CEPHALEXIN Form and strength FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* Sponsor FACTA FARMA Submission history Latest submission status date: 2000-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEPHALEXIN is listed in Drugs@FDA under application 062117 (ANDA). Marketing status: Discontinued Active ingredient CEPHALEXIN Form and strength FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* Sponsor FACTA FARMA Submission history Latest submission status date: 2000-05-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.